HB 1033 Texas House · 87th Legislature (2021)

Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.

Bill status signed all 5 stages cleared
Introduction
Mar 2021
Committee Review
Apr 2021
House Passage
Apr 2021
Senate Passage
May 2021
Signed into Law
May 2021
Introduced Mar 4, 2021 Signed May 18, 2021
Floor votes · House Apr 8, 2021

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
45
Key actions
14
Committee
12
May 18, 2021
Signed into law
Signed by the Governor
executive
May 4, 2021
Upper · Passed
Passed
upper
Apr 19, 2021
Upper · Passed
Committee report printed and distributed
upper
Apr 19, 2021
Upper · Passed
Reported favorably w/o amendments
upper
Apr 12, 2021
Committee
Referred to Business & Commerce
upper
Apr 12, 2021
Introduced
Read first time
upper
Apr 8, 2021
Introduced
Received from the House
upper
Apr 8, 2021
Lower · Passed
Passed
lower
Apr 7, 2021
Lower · Passed
Passed to engrossment
lower
Mar 29, 2021
Lower · Passed
Committee report sent to Calendars
lower
Mar 29, 2021
Lower · Passed
Committee report distributed
lower
Mar 26, 2021
Lower · Passed
Comte report filed with Committee Coordinator
lower
Mar 23, 2021
Lower · Passed
Reported favorably as substituted
lower
Mar 23, 2021
Lower · Passed
Committee substitute considered in committee
lower
Mar 16, 2021
Lower · Passed
Left pending in committee
lower
Mar 16, 2021
Lower · Passed
Testimony taken/registration(s) recorded in committee
lower
Mar 16, 2021
Lower · Passed
Committee substitute considered in committee
lower
Mar 4, 2021
Committee
Referred to Insurance
lower
Mar 4, 2021
Introduced
Read first time
lower
3 primary · 5 co-sponsors

Sponsors